Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

T. C. Lynn; R. P. Hsieh; K. T. Lin; M. C. Shen; D. S. Chen; C. H. Wang; C. H. Liu; J. H. Wang; M. Y. Lai; M. F. Liou; M. R. Hsieh; C. Y. Chuang; R. Ting; Jacqueline Whang-Peng

Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

T. C. Lynn, R. P. Hsieh, K. T. Lin, M. C. Shen, D. S. Chen, C. H. Wang, C. H. Liu, J. H. Wang, M. Y. Lai, M. F. Liou, M. R. Hsieh, C. Y. Chuang, R. Ting, Jacqueline Whang-Peng

研究成果: 雜誌貢獻 › 文章 › 同行評審

摘要

A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

原文	英語
頁（從 - 到）	172-176
頁數	5
期刊	Zhonghua minguo weishengwu ji mianyixue zazhi
卷	17
發行號	3
出版狀態	已發佈 - 8月 1 1984
對外發佈	是

ASJC Scopus subject areas

醫藥 (全部)

UN SDG

此研究成果有助於以下永續發展目標

其它文件與鏈接

引用此

@article{d4509a3fec7d47ea83474e3000c229ce,

title = "Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.",

abstract = "A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.",

author = "Lynn, {T. C.} and Hsieh, {R. P.} and Lin, {K. T.} and Shen, {M. C.} and Chen, {D. S.} and Wang, {C. H.} and Liu, {C. H.} and Wang, {J. H.} and Lai, {M. Y.} and Liou, {M. F.} and Hsieh, {M. R.} and Chuang, {C. Y.} and R. Ting and Jacqueline Whang-Peng",

year = "1984",

month = aug,

day = "1",

language = "English",

volume = "17",

pages = "172--176",

journal = "Zhonghua minguo weishengwu ji mianyixue zazhi",

issn = "0253-2662",

publisher = "Elsevier Taiwan LLC",

number = "3",

}

TY - JOUR

T1 - Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics

T2 - a preliminary report.

AU - Lynn, T. C.

AU - Hsieh, R. P.

AU - Lin, K. T.

AU - Shen, M. C.

AU - Chen, D. S.

AU - Wang, C. H.

AU - Liu, C. H.

AU - Wang, J. H.

AU - Lai, M. Y.

AU - Liou, M. F.

AU - Hsieh, M. R.

AU - Chuang, C. Y.

AU - Ting, R.

AU - Whang-Peng, Jacqueline

PY - 1984/8/1

Y1 - 1984/8/1

N2 - A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

AB - A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

UR - http://www.scopus.com/inward/record.url?scp=0021476276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021476276&partnerID=8YFLogxK

M3 - Article

C2 - 6096089

AN - SCOPUS:0021476276

SN - 0253-2662

VL - 17

SP - 172

EP - 176

JO - Zhonghua minguo weishengwu ji mianyixue zazhi

JF - Zhonghua minguo weishengwu ji mianyixue zazhi

IS - 3

ER -

Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

摘要

ASJC Scopus subject areas

UN SDG

其它文件與鏈接

指紋

引用此